1. New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?. (March 2020) Authors: Rassy, Elie; Parent, Pauline; Lefort, Felix; Boussios, Stergios; Baciarello, Giulia; Pavlidis, Nicholas Journal: Critical reviews in oncology/hematology Issue: Volume 147(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study. (18th February 2022) Authors: Vauchier, Charles; Auclin, Edouard; Barthélémy, Philippe; Carril-Ajuria, Lucia; Ryckewaert, Thomas; Borchiellini, Delphine; Castel-Ajgal, Zahra; Bennamoun, Mostefa; Campedel, Luca; Thiery-Vuillemin, Antoine; Coquan, Elodie; Crouzet, Laurence; Berdah, Jean-François; Chevreau, Christine; Ratta, Raf... Other Names: Silvestris Nicola Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Thyroid‐like follicular renal cell carcinoma with sarcomatoid differentiation and an aggressive clinical course: a case report confirming the presence of the EWSR1:PATZ1 fusion gene. Issue 4 (1st February 2022) Authors: Perret, Raul; Lefort, Felix; Bernhard, Jean‐Christophe; Baud, Jessica; Le Loarer, François; Yacoub, Mokrane Journal: Histopathology Issue: Volume 80:Issue 4(2022) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗